Pharmafile Logo
Pharmafocus logo
Advanced Search

Cinven

Showing 3 posts of 3 posts found.

Stada takeover back in motion after revised bid

July 12, 2017
Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical

Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …

News

Stada CEO and CFO tumble in takeover turmoil

July 4, 2017
Sales and Marketing Bain capital, Cinven, Stada

Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’. Matthias Wiedenfels, …

News

Stada encourages bidding war, with figure of €3.5 billion mooted

February 15, 2017
Research and Development, Sales and Marketing Advent International, Cinven, Stada

Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026